← Back to Clinical Trials
Recruiting NCT07610447

NCT07610447 VR vs Treadmill Exercise in Children With Asthma

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07610447
Status Recruiting
Phase
Sponsor Bezmialem Vakif University
Condition Asthma (Diagnosis)
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-05-25
Primary Completion 2027-05-10

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Virtual Reality-Based Aerobic ExerciseTreadmill-Based Aerobic Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-05-25 with a primary completion date of 2027-05-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the effects of virtual reality-based aerobic exercise and treadmill-based aerobic exercise on functional capacity, pulmonary function, and clinical outcomes in children with asthma. Participants aged 10-17 years with physician-diagnosed asthma will be randomly assigned to either a virtual reality-based exercise group or a treadmill exercise group. Both groups will undergo supervised exercise training sessions twice a week for 8 weeks. Primary outcome will be the 6-Minute Walk Test. Secondary outcomes include pulmonary function, respiratory muscle strength, asthma control, quality of life, and exercise adherence.

Eligibility Criteria

Inclusion Criteria: * Children and adolescents aged between 10 and 17 years * Physician-diagnosed asthma according to Global Initiative for Asthma (GINA) criteria * Stable medical treatment for asthma * Ability to participate in an aerobic exercise program * Willingness of the participant and parent/legal guardian to provide informed consent Exclusion Criteria: * Presence of orthopedic, neurological, cardiovascular, or systemic conditions limiting participation in exercise * Contraindications to virtual reality use (e.g., epilepsy, photosensitivity) * Participation in a structured exercise program within the previous month * Asthma exacerbation within the previous month * Obesity diagnosis

Contact & Investigator

Central Contact

Ayşe Sena Manzak Dursun, PT, PhD

✉ amanzak@bezmialem.edu.tr

📞 +905356735150

Frequently Asked Questions

Who can join the NCT07610447 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 17 Years, studying Asthma (Diagnosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07610447 currently recruiting?

Yes, NCT07610447 is actively recruiting participants. Contact the research team at amanzak@bezmialem.edu.tr for enrollment information.

Where is the NCT07610447 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07610447 clinical trial?

NCT07610447 is sponsored by Bezmialem Vakif University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology